Performance

BCAX -31.83%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
BCAX	+15.38%	-40.70%	-31.83%	—	-73.91%	-0.14	0.00%

Summary

BCAX at a glance

BCAX returned -31.83% over the past year. Its worst drop in that year was -73.91%, smaller than 4% of stocks on Redstone, and its Sharpe ratio of -0.14 beats 21% of stocks on Redstone. It pays no dividends.

Ranking

How BCAX ranks

Current Drawdown

-67.17%

Rolling Volatility

179.72%

Actions

Metrics

Risk Indicators

Alpha-22.76%

Beta1.23x

Sharpe-0.14

Sortino-0.18

Omega0.97

Calmar-0.43

Martin-0.48

Profile

About BCAX

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $660M
Listed: Sep 2024
Employees: 103
Headquarters: Boston, MA
Website: bicara.com

Comparisons

BCAX: Bicara Therapeutics Inc.

BCAX at a glance

How BCAX ranks

Current Drawdown

Rolling Volatility

About BCAX

Related comparisons